B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
MONDO:0035941Also known as: B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged, B lymphoblastic leukaemia lymphoma with t(v;11q23); MLL rearranged, B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged
1852 clinical trials for this condition and its sub-types, 8 tagged with B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New combo tackles tough leukemia
Disease control Not yet recruitingThis early-phase study tests two drugs, blinatumomab and revumenib, given together to adults with a rare and aggressive form of acute lymphoblastic leukemia (ALL) that has a specific genetic change called KMT2A rearrangement. The main goal is to find a safe dose and understand si…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New combo aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThis study tests whether adding a new drug called revumenib to the usual treatment (blinatumomab plus chemotherapy) can better clear leftover leukemia cells in people with a specific genetic type of B-cell acute lymphoblastic leukemia (ALL) or mixed-lineage leukemia. About 90 adu…
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC